RIGH. “This will benefit current shareholders by

RIGH. “This will benefit current shareholders by the acquisition and development of both medical technology and data technology through parallel growth trajectories. Genius Biotech Corporation is in a position to benefit greatly from the continued legalization of medical marijuana, while our crossover products benefit synergistically from emerging recreational marijuana markets.”
http://www.businesswire.com/news/home/2014071...Cv0mxYldpd

http://investorshangout.com/post/postreplies?id=2029981